# Intensified Short Course Regimen for TBM in Adults

> **NCT05917340** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Indian Council of Medical Research** · enrollment: 372 (estimated)

## Conditions studied

- Tuberculous Meningitis

## Interventions

- **DRUG:** High dose rifampicin (25mg/kg)
- **DRUG:** Moxifloxacin 400mg
- **DRUG:** Aspirin 150 mg
- **DRUG:** Isoniazid
- **DRUG:** Pyrazinamide
- **DRUG:** Steroid
- **DRUG:** Rifampicin
- **DRUG:** HRZE
- **DRUG:** HRE

## Key facts

- **NCT ID:** NCT05917340
- **Lead sponsor:** Indian Council of Medical Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-03
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05917340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05917340, "Intensified Short Course Regimen for TBM in Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05917340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*